Top Story

Opioid abuse treatment medications equally effective

November 15, 2017

Buprenorphine-naloxone combination and extended-release naltrexone were both safe and effective in managing patients with opioid use disorder, yielding nearly identical results, according to findings recently published in The Lancet.

“Previous opioid antagonist or agonist comparisons have evaluated oral naltrexone and long-term naltrexone implants, but not monthly extended-release naltrexone treatment,” Joshua D. Lee, MD, department of population health, New York University School of Medicine, and colleagues wrote. “Important clinical issues remain unanswered, beyond the established efficacy of either extended-release naltrexone or buprenorphine-naloxone.”

FDA NewsPerspective

FDA authorizes marketing of device to reduce opioid withdrawal symptoms

November 15, 2017
The FDA granted marketing authorization of an electronic stimulation device to aid in reducing the symptoms associated with opioid withdrawal. The NSS-2 Bridge device…

FDA warns against use of kratom

November 14, 2017
The FDA issued a warning today about the potentially fatal risks linked to kratom, a plant-based product from Asia that the agency said is used to treat medical…
In the Journals

Childhood spanking negatively affects adult mental health

November 9, 2017
Childhood spanking was associated with increased risk for suicide attempts, moderate-to-heavy drinking and illicit drug use in adulthood. “Child maltreatment has…
More Headlines »
CME Article

Neuropsychiatric Complications of Injection-Associated Diseases: HIV and Hepatitis C

Psychiatric Annals, January 2017, Volume 47 Issue 1
Intravenous use of illicit substances increases the risk for transmission of hepatitis C virus (HCV) and human…
More »

Overview of Consultation-Liaison Psychiatry: April 2017

Keck School of Medicine of USC and Psychiatric Annals

There is no health without psychiatric health. Psychiatric disorders are not only highly prevalent, but they are even…
More »
Resource Centers
Psych Congress

Psych Congress

Meeting News

VIDEO: How cannabis policies will affect psychiatric practice

September 18, 2017
More »